Hypothesis versus association: the optimal hemoglobin target debate

Am J Kidney Dis. 2005 Nov;46(5):970-3. doi: 10.1053/j.ajkd.2005.09.009.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / etiology
  • Bias
  • Biomarkers
  • Chronic Disease
  • Epoetin Alfa
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use
  • Goals
  • Hemoglobins / analysis*
  • Humans
  • Hypertrophy, Left Ventricular / etiology
  • Hypertrophy, Left Ventricular / prevention & control
  • Kidney Diseases / blood
  • Kidney Diseases / complications
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Reference Values
  • Research Design
  • Treatment Outcome

Substances

  • Biomarkers
  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
  • Epoetin Alfa